Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31968 ↗At a glance
Journal article in Pediatric Blood & Cancer, 2025. Written by Mallory R Taylor and 12 co-authors. Institution: Department of Pediatrics, Division of Hematology/Oncology, University of Washington, Seattle, Washington, USA. Major MEDLINE topics: Neuroblastoma, N-Myc Proto-Oncogene Protein. Cited 3 times so far (Crossref); 23 references.
Abstract (original language)
Background Toddlers (age 365–
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pediatrics, Division of Hematology/Oncology, University of Washington, Seattle, Washington, USA.
- Ben Towne Center For Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA.
- College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
- Department of Pediatrics, University of Chicago, Chicago, Illinois, USA.
ORCID profiles: Mallory R Taylor, Meredith S Irwin, Mark A Applebaum, Keri Streby, Miki Ohira, Wendy B London
Cite
APA
Taylor, M. R., Anderson, J. R., Park, J. R., Irwin, M. S., Applebaum, M. A., Pinto, N. R., Streby, K., Federico, S. M., Rosswog, C., Ohira, M., Kao, P. C., London, W. B., & Cash, T. (2025). Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31968
Vancouver
Taylor MR, Anderson JR, Park JR, Irwin MS, Applebaum MA, Pinto NR, et al. Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31968
BibTeX
@article{Taylor2025,
author = {Taylor, Mallory R and Anderson, James R and Park, Julie R and Irwin, Meredith S and Applebaum, Mark A and Pinto, Navin R and Streby, Keri and Federico, Sara M and Rosswog, Carolina and Ohira, Miki and Kao, Pei-Chi and London, Wendy B and Cash, Thomas},
title = {Outcomes for Patients Aged 12–18 Months With Metastatic MYCN Non‐Amplified Neuroblastoma and Unfavorable Biologic Features (“Mixed Biology Toddlers”): A Report From the International Neuroblastoma Risk Group (INRG) Project},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31968}
}
EUVIMED